These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3437251)

  • 21. Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro.
    Bicknell RJ; Chapman C; Leng G
    Neuroendocrinology; 1985 Aug; 41(2):142-8. PubMed ID: 2864649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
    Ishikawa S; Schrier RW
    J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study.
    Neumann I; Russell JA; Wolff B; Landgraf R
    Neuroendocrinology; 1991 Dec; 54(6):545-51. PubMed ID: 1784342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of oxytocin into blood and into cerebrospinal fluid induced by naloxone in anaesthetized morphine-dependent rats: the role of the paraventricular nucleus.
    Coombes JE; Robinson IC; Antoni FA; Russell JA
    J Neuroendocrinol; 1991 Oct; 3(5):551-61. PubMed ID: 19215505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats.
    Iványi T; Dohanics J; Verbalis JG
    Neuroendocrinology; 1995 Apr; 61(4):412-20. PubMed ID: 7783854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous opioid inhibition of the release of oxytocin from the isolated rat neurohypophysis during high-frequency stimulation of the pituitary stalk.
    Wammack R; Racké K
    Neurosci Lett; 1988 Sep; 92(1):114-8. PubMed ID: 3185974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.
    Coiro V; Chiodera P
    Neuroendocrinology; 1991 Mar; 53(3):209-13. PubMed ID: 2041583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycemia in man.
    Chiodera P; Coiro V
    J Neural Transm Gen Sect; 1991; 83(1-2):121-6. PubMed ID: 1673342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-aminobutyric acid mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking.
    Chiodera P; Volpi R; Capretti L; Bocchi R; Caffarri G; Marcato A; Rossi G; Coiro V
    Metabolism; 1993 Jun; 42(6):762-5. PubMed ID: 8510522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diurnal rhythm of vasopressin but not of oxytocin in the cerebrospinal fluid of the goat: lack of association with plasma cortisol rhythm.
    Seckl JR; Lightman SL
    J Endocrinol; 1987 Sep; 114(3):477-82. PubMed ID: 3668436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
    Bondy CA; Gainer H; Russell JT
    Endocrinology; 1988 Apr; 122(4):1321-7. PubMed ID: 2894296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone affects the release of cortisol, but not of vasopressin or oxytocin, in dehydrated sheep.
    Thornton SN; Parrott RF
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):50-4. PubMed ID: 2911940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioids influence neurohypophysial but not central oxytocin release following direct hyperosmotic stimulation of the supraoptic nucleus in urethane-anaesthetised rats.
    Munro G; Ludwig M; Landgraf R; Russell JA
    Neuropeptides; 1994 Aug; 27(2):121-7. PubMed ID: 7991066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies.
    Hyde JF; Ben-Jonathan N
    Endocrinology; 1989 Aug; 125(2):736-41. PubMed ID: 2526728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
    Ciosek J
    J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release.
    Zhao BG; Chapman C; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats.
    Seckl JR; Lightman SL
    Brain Res; 1987 Oct; 423(1-2):279-85. PubMed ID: 3676810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid-noradrenergic interactions in the neurohypophysis. II. Does noradrenaline mediate the actions of endogenous opioids on oxytocin and vasopressin release?
    Zhao BG; Chapman C; Brown D; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):25-31. PubMed ID: 2845292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginocervical stimulation releases oxytocin within the spinal cord in rats.
    Sansone GR; Gerdes CA; Steinman JL; Winslow JT; Ottenweller JE; Komisaruk BR; Insel TR
    Neuroendocrinology; 2002 May; 75(5):306-15. PubMed ID: 12006784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men.
    Coiro V; Capretti L; Speroni G; Castelli A; Bianconi L; Cavazzini U; Marcato A; Volpi R; Chiodera P
    J Endocrinol Invest; 1990 Oct; 13(9):757-63. PubMed ID: 2292659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.